[(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate

C34H50O11 — CID 125029144

IUPAC[(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate
SMILESCO[C@@H]1[C@@H](OC(C)=O)[C@H](C)O[C@H](O[C@@H]2CC[C@]3(C)[C@@H]4CC[C@]5(C)[C@H](C6=CC(=O)OC6)CC[C@]5(O)[C@H]4CC[C@@]3(O)C2)[C@@H]1OC(C)=O
InChIInChI=1S/C34H50O11/c1-18-27(43-19(2)35)28(40-6)29(44-20(3)36)30(42-18)45-22-7-11-31(4)24-8-12-32(5)23(21-15-26(37)41-17-21)10-14-34(32,39)25(24)9-13-33(31,38)16-22/h15,18,22-25,27-30,38-39H,7-14,16-17H2,1-6H3/t18-,22+,23-,24+,25-,27-,28+,29+,30+,31+,32+,33+,34-/m0/s1
InChIKeyQTKBDFJFNUTVKR-AHJCERBFSA-N
MW634.76 g/mol
LogP3.37
Rot. Bonds6

About [(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate

[(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate (PubChem CID 125029144) has the molecular formula C34H50O11 and a molecular weight of 634.76 g/mol. Its IUPAC name is [(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate.

Molecular Properties

Compound Name[(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate
PubChem CID125029144
Molecular FormulaC34H50O11
Molecular Weight634.76 g/mol
Exact Mass634.34
IUPAC Name[(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate
SMILESCO[C@@H]1[C@@H](OC(C)=O)[C@H](C)O[C@H](O[C@@H]2CC[C@]3(C)[C@@H]4CC[C@]5(C)[C@H](C6=CC(=O)OC6)CC[C@]5(O)[C@H]4CC[C@@]3(O)C2)[C@@H]1OC(C)=O
InChIInChI=1S/C34H50O11/c1-18-27(43-19(2)35)28(40-6)29(44-20(3)36)30(42-18)45-22-7-11-31(4)24-8-12-32(5)23(21-15-26(37)41-17-21)10-14-34(32,39)25(24)9-13-33(31,38)16-22/h15,18,22-25,27-30,38-39H,7-14,16-17H2,1-6H3/t18-,22+,23-,24+,25-,27-,28+,29+,30+,31+,32+,33+,34-/m0/s1
InChIKeyQTKBDFJFNUTVKR-AHJCERBFSA-N
XLogP3.37
TPSA147.05 Ų
H-Bond Donors2
H-Bond Acceptors11
Rotatable Bonds6
Heavy Atoms45
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500634.76
LogP ≤ 53.37
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 1011

Computed Properties (RDKit)

Structural Alerts{'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'saponine_derivative', 'substructure': 'N/A'}

Analyze [(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate?
The IUPAC name of [(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate (CID 125029144) is [(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate.
What is the SMILES notation for [(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate?
The canonical SMILES for [(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate is CO[C@@H]1[C@@H](OC(C)=O)[C@H](C)O[C@H](O[C@@H]2CC[C@]3(C)[C@@H]4CC[C@]5(C)[C@H](C6=CC(=O)OC6)CC[C@]5(O)[C@H]4CC[C@@]3(O)C2)[C@@H]1OC(C)=O.
What is the InChIKey of [(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate?
The InChIKey is QTKBDFJFNUTVKR-AHJCERBFSA-N. The full InChI is InChI=1S/C34H50O11/c1-18-27(43-19(2)35)28(40-6)29(44-20(3)36)30(42-18)45-22-7-11-31(4)24-8-12-32(5)23(21-15-26(37)41-17-21)10-14-34(32,39)25(24)9-13-33(31,38)16-22/h15,18,22-25,27-30,38-39H,7-14,16-17H2,1-6H3/t18-,22+,23-,24+,25-,27-,28+,29+,30+,31+,32+,33+,34-/m0/s1.
What are the key properties of [(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate?
[(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate has a molecular weight of 634.76 g/mol, XLogP of 3.37, 6 rotatable bonds, 2 hydrogen bond donors, and 11 hydrogen bond acceptors.
Where does this data come from?
All data for [(2S,3S,4R,5R,6S)-5-acetyloxy-6-[[(3R,5R,8S,9R,10R,13R,14S,17S)-5,14-dihydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]oxy]-4-methoxy-2-methyloxan-3-yl] acetate is sourced from PubChem (CID 125029144), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).